Daihong Liu
Overview
Explore the profile of Daihong Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
146
Citations
1069
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang J, Liu Q, Zhang X, Jing Y, Le N, Li M, et al.
Int Immunopharmacol
. 2025 Feb;
151:114268.
PMID: 39986194
Acute myeloid leukemia (AML) is a highly heterogeneous hematopoietic malignancy characterized by elevated mortality. Epigenetic therapy plays an essential role in the treatment of AML. However, the clinical outcomes of...
2.
Ren H, Huang J, Huang Y, Long B, Zhang M, Zhang J, et al.
Cancer Imaging
. 2025 Jan;
25(1):8.
PMID: 39885549
Background: Previous studies utilizing dual-energy CT (DECT) for evaluating treatment efficacy in nasopharyngeal cancinoma (NPC) are limited. This study aimed to investigate whether the parameters from DECT can predict the...
3.
Zheng J, Wang C, Zhou X, Tang Y, Tang L, Tan Y, et al.
Brain Res Bull
. 2025 Jan;
221:111210.
PMID: 39832755
Background: Cancer pain is a common symptom in patients with malignant tumors and associated with poor prognosis and a high risk of death. Structural connectivity (SC) and functional connectivity (FC)...
4.
Jiang E, Qian K, Wang L, Yang D, Shao Y, Hu L, et al.
BMC Med
. 2024 Nov;
22(1):555.
PMID: 39587570
Background: Failure of systemic corticosteroid therapy is common in patients with newly diagnosed acute graft-versus-host disease (aGVHD) above grade II. Mesenchymal stem cells (MSCs) have been used as a tolerable...
5.
Dou L, Zhao Y, Yang J, Deng L, Wang N, Zhang X, et al.
Signal Transduct Target Ther
. 2024 Oct;
9(1):288.
PMID: 39438467
Newly diagnosed patients with high-risk acute graft-versus-host disease (aGVHD) often experience poor clinical outcomes and low complete remission rates. Ruxolitinib with corticosteroids showed promising efficacy in improving response and failure...
6.
Wang X, Ba R, Huang Y, Cao Y, Chen H, Xu H, et al.
Radiology
. 2024 Oct;
313(1):e240288.
PMID: 39436292
Background Time-dependent diffusion MRI has the potential to help characterize tumor cell properties; however, to the knowledge of the authors, its usefulness for breast cancer diagnosis and prognostic evaluation is...
7.
Ran L, Liu J, Lan X, Zhou X, Tan Y, Zhang J, et al.
Brain Imaging Behav
. 2024 Oct;
18(6):1524-1535.
PMID: 39356440
To investigative the white matter (WM) alterations in lung cancer patients with cancer pain (CP+), and explore the correlations between damaged WM fiber tracts and clinical indicators. Twenty-six CP+, 26...
8.
Hu Y, Lei W, Xin E, Cheng T, Liu J, Tang Y, et al.
Clin Exp Metastasis
. 2024 Oct;
41(6):959-969.
PMID: 39352614
The distribution of brain metastases (BMs) in patients with lung cancer may be associated with the primary tumor-related factors and cerebral small vascular diseases (CSVDs). The aim of this study...
9.
Wang Y, Chang Y, Chen J, Han M, Hu J, Hu J, et al.
Cancer Lett
. 2024 Sep;
605:217264.
PMID: 39332587
The consensus in 2018 from The Chinese Society of Haematology (CSH) on the monitoring, treatment, and prevention of leukaemia relapse after allogeneic haematopoietic stem cell transplantation (HSCT) facilitated the standardization...
10.
Wei Y, Qian K, Le N, Wang L, Li F, Luan S, et al.
Ann Hematol
. 2024 Sep;
103(11):4707-4719.
PMID: 39243311
The prognosis of patients with high-risk acute myeloid leukemia (AML) is dismal even after allogeneic stem cell transplantation (allo-HSCT), with relapse remaining the leading cause of treatment failure. Here, we...